Analysen von Keyur Parekh
| 21.03.18 | Merck Neutral | Goldman Sachs Group Inc. | |
| 14.03.18 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 13.03.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 13.03.18 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 09.03.18 | Merck Neutral | Goldman Sachs Group Inc. | |
| 08.03.18 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 02.03.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 02.03.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 07.02.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 29.01.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 25.01.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 23.01.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 23.01.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 09.01.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 15.12.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 29.11.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 27.11.17 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 20.11.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 08.11.17 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 03.11.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 31.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 25.10.17 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 25.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 17.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 17.10.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 28.09.17 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 19.09.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 06.09.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 17.08.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 08.08.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 08.08.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 07.08.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 04.08.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 01.08.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 27.07.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 26.07.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 24.07.17 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 19.07.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.07.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 23.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 02.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 24.05.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 19.05.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 17.05.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 02.05.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 26.04.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 27.03.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 23.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |